| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Interim President &CEO | See Remarks
1 company
Gould Robert J is a Director at FULC. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $4.9M at current prices.
Our model assigns Gould Robert J a strong insider score of 85/100, based on 13 past trades. Over a 12-month horizon, 81.8% of those trades were profitable, with an average 12-month return of +52.0%.
Gould Robert J's largest disclosed position is in FULC as Director, worth about $4.9M. The recent filings there lean toward selling, a net 340,420 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | FULC Fulcrum Therapeutics, Inc. | Director | Sell | 15,000 | $10.72 | $160,857.00 | -3.2% | -34.5% | - | |
| Jan 2, 2026 | FULC Fulcrum Therapeutics, Inc. | Director | Sell | 15,000 | $11.87 | $178,089.00 | -3.1% | -26.4% | - | |
| Nov 19, 2025 | FULC Fulcrum Therapeutics, Inc. | Director | Sell | 15,000 | $11.03 | $165,495.00 | -3.0% | -7.4% | - | |
| Jan 13, 2023 | FULC Fulcrum Therapeutics, Inc. | Interim President &CEO | Sell | 6,766 | $15.00 | $101,490.00 | -1.3% | -81.7% | -48.2% | |
| Jun 7, 2022 | FULC Fulcrum Therapeutics, Inc. | Director | Sale+OE | 71,435 | $8.09 | $577,894.86 | -12.4% | -7.3% | -60.9% | |
| Jun 6, 2022 | FULC Fulcrum Therapeutics, Inc. | Director | Sale+OE | 66,622 | $8.00 | $532,809.94 | -11.6% | -0.8% | -58.2% | |
| Apr 7, 2022 | FULC Fulcrum Therapeutics, Inc. | Director | Sale+OE | 5,631 | $24.02 | $135,228.47 | -1.1% | -76.5% | -89.6% | |
| Apr 5, 2022 | FULC Fulcrum Therapeutics, Inc. | Director | Sale+OE | 94,251 | $24.16 | $2,276,683.71 | -15.7% | -77.0% | -89.9% | |
| Mar 16, 2021 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 10,000 | $12.16 | $121,578.33 | -1.9% | -28.7% | +41.5% | |
| Feb 16, 2021 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 8,215 | $14.27 | $117,197.40 | -1.6% | - | - |